Vor Biopharma Inc (NASDAQ: VOR) is -68.14% lower on its value in year-to-date trading and has touched a low of $0.63 and a high of $3.14 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VOR stock was last observed hovering at around $0.68 in the last trading session, with the day’s gains setting it 0.04%.
Currently trading at $0.72, the stock is 1.68% and -14.54% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.63 million and changing 6.16% at the moment leaves the stock -52.30% off its SMA200. VOR registered -69.75% loss for a year compared to 6-month loss of -57.33%. The firm has a 50-day simple moving average (SMA 50) of $0.83884 and a 200-day simple moving average (SMA200) of $1.50284.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -23.26% gain in the last 1 month and extending the period to 3 months gives it a -22.35%, and is 9.50% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.00% over the week and 9.26% over the month.
Vor Biopharma Inc (VOR) has around 168 employees, a market worth around $49.04M and $0.00M in sales. Distance from 52-week low is 13.79% and -77.17% from its 52-week high. The company has generated returns on investments over the last 12 months (-92.41%).
The EPS is expected to grow by 11.93% this year
92.0 institutions hold shares in Vor Biopharma Inc (VOR), with institutional investors hold 82.09% of the company’s shares. The shares outstanding are 67.89M, and float is at 59.59M with Short Float at 3.31%. Institutions hold 81.12% of the Float.
The top institutional shareholder in the company is RA CAPITAL MANAGEMENT, L.P. with over 22.75 million shares valued at $22.75 million. The investor’s holdings represent 33.439 of the VOR Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 7.08 million shares valued at $7.08 million to account for 10.4009 of the shares outstanding. The other top investors are PARADIGM BIOCAPITAL ADVISORS LP which holds 6.46 million shares representing 9.4917 and valued at over $6.46 million, while 5AM VENTURE MANAGEMENT, LLC holds 9.3512 of the shares totaling 6.36 million with a market value of $6.36 million.
Vor Biopharma Inc (VOR) Insider Activity
The most recent transaction is an insider sale by Attar Eyal C., the company’s CHIEF MEDICAL OFFICER. SEC filings show that Attar Eyal C. sold 14,645 shares of the company’s common stock on Jun 03 ’24 at a price of $1.39 per share for a total of $20357.0. Following the sale, the insider now owns 96063.0 shares.
